To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Esquire Capital Holdings on the biotech hunt
The Luxembourg-based investment house is looking to raise $40m to invest in international life science companies.
